These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 24857146)

  • 1. The horizon of precision medicine in breast cancer: fragmentation, alliance, or reunification?
    Andre F; Vicier C; Delaloge S
    Am Soc Clin Oncol Educ Book; 2014; ():e5-10. PubMed ID: 24857146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [BREAST CANCER: FROM TARGETED THERAPY TO PRECISION MEDICINE].
    Jerusalem G; Collignon J; Josse C; Schroeder H; Rorive A; Frères P; Lambert F; Koopmansch B; Poncin A; Bours V
    Rev Med Liege; 2015; 70(5-6):269-76. PubMed ID: 26285451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Target therapy for metastatic breast cancer.
    Rachdi H; Mokrani A; Batti R; Ayadi M; Chraiet N; Mezlini A
    Tunis Med; 2018; 96(8-9):465-471. PubMed ID: 30430522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of triple-negative metastatic breast cancer: toward individualized targeted treatments or chemosensitization?
    Berrada N; Delaloge S; André F
    Ann Oncol; 2010 Oct; 21 Suppl 7():vii30-5. PubMed ID: 20943632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is precision medicine ready for use in breast cancer?
    Pusztai L
    Clin Adv Hematol Oncol; 2016 Dec; 14(12):964-966. PubMed ID: 28212357
    [No Abstract]   [Full Text] [Related]  

  • 6. Successes and limitations of targeted cancer therapy in breast cancer.
    Curigliano G; Criscitiello C
    Prog Tumor Res; 2014; 41():15-35. PubMed ID: 24727984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Precision Medicine and Targeted Therapies in Breast Cancer.
    Greenwalt I; Zaza N; Das S; Li BD
    Surg Oncol Clin N Am; 2020 Jan; 29(1):51-62. PubMed ID: 31757313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defining precision: The precision medicine initiative trials NCI-MPACT and NCI-MATCH.
    Coyne GO; Takebe N; Chen AP
    Curr Probl Cancer; 2017; 41(3):182-193. PubMed ID: 28372823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Precision medicine for advanced prostate cancer.
    Mullane SA; Van Allen EM
    Curr Opin Urol; 2016 May; 26(3):231-9. PubMed ID: 26909474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Precision medicine in breast cancer: genes, genomes, and the future of genomically driven treatments.
    Stover DG; Wagle N
    Curr Oncol Rep; 2015 Apr; 17(4):15. PubMed ID: 25708799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Precision medicine for metastatic breast cancer.
    Deluche E; Onesti E; Andre F
    Am Soc Clin Oncol Educ Book; 2015; ():e2-7. PubMed ID: 25993174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Precision medicine in pediatric oncology.
    Forrest SJ; Geoerger B; Janeway KA
    Curr Opin Pediatr; 2018 Feb; 30(1):17-24. PubMed ID: 29189430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted therapy in cancer.
    Tsimberidou AM
    Cancer Chemother Pharmacol; 2015 Dec; 76(6):1113-32. PubMed ID: 26391154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Precision Medicine in Pediatric Oncology.
    Vo KT; Parsons DW; Seibel NL
    Surg Oncol Clin N Am; 2020 Jan; 29(1):63-72. PubMed ID: 31757314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integration of Comprehensive Genomic Analysis and Functional Screening of Affected Molecular Pathways to Inform Cancer Therapy.
    Vasmatzis G; Liu MC; Reganti S; Feathers RW; Smadbeck J; Johnson SH; Schaefer Klein JL; Harris FR; Yang L; Kosari F; Murphy SJ; Borad MJ; Thompson EA; Cheville JC; Anastasiadis PZ
    Mayo Clin Proc; 2020 Feb; 95(2):306-318. PubMed ID: 31685261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA applications for prostate, ovarian and breast cancer in the era of precision medicine.
    Smith B; Agarwal P; Bhowmick NA
    Endocr Relat Cancer; 2017 May; 24(5):R157-R172. PubMed ID: 28289080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Precision medicine for metastatic breast cancer--limitations and solutions.
    Arnedos M; Vicier C; Loi S; Lefebvre C; Michiels S; Bonnefoi H; Andre F
    Nat Rev Clin Oncol; 2015 Dec; 12(12):693-704. PubMed ID: 26196250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management and Outcomes in Metaplastic Breast Cancer.
    Tzanninis IG; Kotteas EA; Ntanasis-Stathopoulos I; Kontogianni P; Fotopoulos G
    Clin Breast Cancer; 2016 Dec; 16(6):437-443. PubMed ID: 27431460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toward precision medicine in glioblastoma: the promise and the challenges.
    Prados MD; Byron SA; Tran NL; Phillips JJ; Molinaro AM; Ligon KL; Wen PY; Kuhn JG; Mellinghoff IK; de Groot JF; Colman H; Cloughesy TF; Chang SM; Ryken TC; Tembe WD; Kiefer JA; Berens ME; Craig DW; Carpten JD; Trent JM
    Neuro Oncol; 2015 Aug; 17(8):1051-63. PubMed ID: 25934816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting Stemness: Implications for Precision Medicine in Breast Cancer.
    Liang ZM; Chen Y; Luo ML
    Adv Exp Med Biol; 2017; 1026():147-169. PubMed ID: 29282683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.